Ankylosing spondylitis trials in Spain

In Spain 7 Also abroad 89

7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Where
Barcelona, Bilbao, Ciudad Real, Córdoba, Elche, Las Palmas De Gran Canaria, Madrid, Murcia, Orihuela, Palma, San Cristóbal de La Laguna, Santander, Sant Joan d'Alacant, Torrelavega, Vitoria, Hospital laredo
Age
50 years and over
People
1,944
Run by
Instituto de Investigación Marqués de Valdecilla
See details and how to joinNCT07611747 · EU 2025-521086-28-00
Phase 4Taking people
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Where
Bilbao, Madrid, Sabadell, Santiago de Compostela, Sevilla, Valencia
People
339 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00
Phase 3Taking people
An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
Where
Esplugues De Llobregat, Madrid, Valencia
Age
2 years to 18 years
People
40 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06668181 · EU 2023-508845-41-00
Phase 1Taking people
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial-1)
Where
Córdoba, Madrid, Sabadell
Age
18 years and over
People
86 worldwide
Run by
Grey Wolf Therapeutics Limited
See details and how to join2025-521315-39-00 · EU 2025-521315-39-00
Phase 1Taking people
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
Where
Barcelona
Age
18 years and over
People
20 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT06888193 · EU 2024-518689-29-00
Phase 1/2Taking people
EAST-1 (ERAP-inhibition in Axial Spondyloarthritis Trial - 1)
Where
Córdoba, Madrid, Sabadell
Age
18 years to 65 years
People
140 worldwide
Run by
Grey Wolf Therapeutics
See details and how to joinNCT07047703
Phase 4Not yet taking people in Spain
Impact Of Upadacitinib On The Frequency Of Acute Recurrent Anterior Uveitis In Patients With Axial Spondyloarthritis
Where
Cordoba, Madrid, Sabadell
Age
18 years and over
People
200 worldwide
Run by
CARE ARTHRITIS LTD.
See details and how to joinNCT07018206 · EU 2025-522118-21-00